Journal of Neuro-Oncology

, Volume 87, Issue 1, pp 91–95 | Cite as

A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment

Clinical-Patient Studies

Abstract

Objective and importance Thyrotroph cell adenoma accounts for only 1% of all pituitary adenomas. This tumor is tough and firm because of significant interstitial fibrosis, and is difficult to remove. Atypical adenoma has an aggressive biological character, invades the surrounding structures, and grows rapidly. Atypical thyrotroph cell adenoma is extremely rare. Clinical presentation A 32-year-old man presented with hyperthyroidism and bitemporal hemianopsia. Head magnetic resonance imaging revealed a large sellar tumor compressing the optic chiasma and invading the left cavernous sinus. Intervention Transsphenoidal surgery was performed and subtotal removal was achieved. Histological examination showed atypical thyrotroph cell adenoma. Gamma knife surgery was planned, but the tumor re-grew within 3 months, and reattached to the optic chiasma. Second transcranial surgery failed to remove residual tumor behind the pituitary stalk. Conventional irradiation followed by octreotide administration resulted in decreased tumor size and stable euthyroidism. The tumor has been controlled for 22 months since first surgery and diagnosis. Conclusion Atypical thyrotroph cell adenoma has an aggressive biological character and grows rapidly. Multimodal treatment including medication and radiotherapy is required.

Keywords

Atypical Ki-67 Pituitary P53 Thyrotroph 

References

  1. 1.
    Bertholon-Greoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519–527CrossRefGoogle Scholar
  2. 2.
    Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. International Agency for Research on Cancer, LyonGoogle Scholar
  3. 3.
    Kovacs K, Horvath E (eds) (1986) Tumors of the pituitary gland, 2nd series. Armed Forces Institute of Pathology, WashingtonGoogle Scholar
  4. 4.
    Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433–442PubMedCrossRefGoogle Scholar
  5. 5.
    Sanno N, Teramoto A, Osamura Y (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179–186PubMedCrossRefGoogle Scholar
  6. 6.
    Lloyd RV, Kovacs K, Young WF Jr, Farrel WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 10–13Google Scholar
  7. 7.
    Kontogeorgos G (2005) Classification and pathology of pituitary tumors. Endocrine 28:27–35PubMedCrossRefGoogle Scholar
  8. 8.
    Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179–188PubMedCrossRefGoogle Scholar
  9. 9.
    Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156:203–216PubMedCrossRefGoogle Scholar
  10. 10.
    Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr (1996) P53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765–771PubMedCrossRefGoogle Scholar
  11. 11.
    Ikeda H, Ogawa Y, Yoshimoto T (1999) Ultrastructural characteristics of TSH-producing adenomas with special reference to its close similarity to BFA-treated pituitary adenoma cells. Pituitary 1:221–226PubMedCrossRefGoogle Scholar
  12. 12.
    Ogawa Y, Ikeda H, Yoshimoto T (1996) Ultrastructural changes in cells of human pituitary adenoma treated by Brefeldin A. Jpn J Clin Electron Microsc 29:69–75Google Scholar
  13. 13.
    Ogawa Y, Tominaga T, Ikeda H (2007) Intrasellar small TSH secreting pituitary adenomas, 2 case reports. No Shinkei Geka 35:679–684PubMedGoogle Scholar
  14. 14.
    Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486PubMedCrossRefGoogle Scholar
  15. 15.
    Patrick AW, Atkin SL, MacKenzie J, Foy PM, White MC, MacFarlane IA (1994) Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH alpha-subunit and GH. Clin Endocrinol (Oxf) 40:275–278Google Scholar
  16. 16.
    Sanno N, Teramoto A, Osamura Y (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194–200PubMedCrossRefGoogle Scholar
  17. 17.
    Beck-Peccoz P, Persani L (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83–88PubMedCrossRefGoogle Scholar
  18. 18.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849–2853PubMedCrossRefGoogle Scholar
  19. 19.
    Dhillon KS, Cohan P, Kelly DF, Darwin CH, Iyer KV, Chopra IJ (2004) Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. J Clin Endocrinol Metab 89:708–711PubMedCrossRefGoogle Scholar
  20. 20.
    Mixson AJ, Friedman TC, David AK (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529–533PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2007

Authors and Affiliations

  1. 1.Department of NeurosurgeryKohnan HospitalSendaiJapan
  2. 2.Department of NeurosurgeryTohoku Graduate School of MedicineSendaiJapan

Personalised recommendations